TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Varmus: Why are scientific societies obstructing public access to research results? May 20, 2005
TCL Archive A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion. June 4, 2004
